Full-Time

Senior Account Executive

Dental SaaS Net New Business

Posted on 8/22/2026

Henry Schein

Henry Schein

10,001+ employees

Global healthcare product distributor and services

Compensation Overview

$70k - $78k/yr

+ OTE $130,000-$145,000

Remote in USA

Remote

Remote within the United States, with up to 35% travel as needed. Not currently hiring residents of Delaware, Hawaii, North Dakota, Rhode Island, Vermont, Puerto Rico, or other U.S. territories.

Bachelor's

Category
Sales & Account Management (1)
Required Skills
Sales
Forecasting
Product Management
Public Speaking
CRM
Salesforce

Get referred to Henry Schein

See people who can refer or advise you

Requirements
  • Typically, 5 to 8 or more years of sales, business development, or related experience in enterprise software or software as a service.
  • Typically, a bachelor's degree or global equivalent in a related discipline.
  • Demonstrated success in acquiring and growing enterprise accounts in software as a service or enterprise software markets.
  • Proven expertise in new business development, consultative sales, and account expansion within competitive industries.
  • Ability to communicate, influence, and drive strategic alignment with customers.
  • Experience leveraging Salesforce and other customer relationship management tools for pipeline management and forecasting.
  • Knowledge of enterprise contracting and navigating complex agreements.
  • Verbal and written communication skills for articulating value propositions and return on investment to executive audiences.
  • Presentation and public speaking skills, including the ability to lead customer and prospect meetings with executive stakeholders.
  • Ability to translate customer needs into actionable solutions.
  • Planning and organizational skills to prioritize opportunities effectively and manage complex sales cycles.
  • Negotiation skills focused on creating mutually beneficial outcomes for the company and customers.
  • Ability to influence and build trusted relationships with internal and external stakeholders.
  • Financial acumen to align sales strategies with business profitability.
Responsibilities
  • Achieve revenue and new bookings quotas by identifying, pursuing, and securing new business opportunities with large enterprise accounts.
  • Build and nurture professional relationships with prospective and existing customers' executive and account teams.
  • Represent the full portfolio of products and services to new and existing accounts.
  • Develop and execute tailored sales strategies to penetrate new markets, close deals, and ensure customer success.
  • Leverage OneSchein partnerships and resources to strengthen customer relationships and drive mutual growth.
  • Collaborate with Solution Engineering, Customer Success, Product Management, and Services teams to design and deliver solutions aligned with customer goals.
  • Conduct account planning and ensure a seamless transition from prospecting to onboarding and account management.
  • Negotiate terms, create contracts, and close large, multi-year agreements with enterprise-level customers.
Desired Qualifications
  • Five or more years of sales, business development, or related experience in enterprise software or software as a service in the dental or healthcare industry.
  • Demonstrated success in acquiring and growing enterprise accounts in software as a service or enterprise software markets with dental technology or healthcare experience.

Henry Schein is a global supplier of healthcare products and services. It operates in two segments: healthcare distribution, which provides dental and medical consumables, equipment, and laboratory products to dentists, physicians, and veterinarians; and technology and value-added services, which offers practice management software, e-commerce solutions, and financial services. The company works by supplying healthcare professionals with a broad range of products and by offering software, online tools, and financing options to run their practices more efficiently. Compared with competitors, Henry Schein combines a wide product catalog with software and financial services, creating a one-stop platform for practice needs across more than 30 countries, with a strong focus on North America. Its goal is to be a trusted partner for healthcare professionals by supporting their day-to-day operations and growth through integrated distribution, technology, and financing solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Town of Huntington, New York

Founded

1932

Get referred to Henry Schein

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue reached $3.46 billion, and management raised full-year guidance on August 4.
  • US dental merchandise sales rose 8.3% in Q2 2026, showing share gains.
  • Value-creation savings start in Q3 2026, with Q4 earnings expected above Q3.

What critics are saying

  • Henry Schein faces ongoing antitrust litigation baggage from the Benco and Patterson dental conspiracy cases.
  • The July 30, 2026 leadership overhaul removes Ettinger, Mlotek, and Mullins, signaling instability.
  • Freight, tariff, and restructuring costs threaten margins if Q3 2026 savings slip.

What makes Henry Schein unique

  • Henry Schein serves over one million dental, medical, and veterinary customers globally.
  • Its 2026 value-creation plan targets $200 million operating income improvement and one-platform execution.
  • The company combines distribution, practice software, e-commerce, and financing in one vendor stack.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Parental Leave

Short Term Disability

Health Savings Account/Flexible Spending Account

Education Benefits

Growth & Insights and Company News

Headcount

6 month growth

6%

1 year growth

6%

2 year growth

6%
Yahoo Finance
Aug 13th, 2026
Henry Schein beats Q2 estimates with $3.46B revenue, raises full-year guidance on dental growth

Henry Schein reported second-quarter results that exceeded Wall Street expectations, with revenue of $3.46 billion versus analyst estimates of $3.37 billion and adjusted EPS of $1.27 versus $1.24 expected. The company attributed the performance to accelerating internal sales growth and robust gains in its global dental merchandise segment. CEO Frederick Lowery highlighted success in converting occasional buyers into regular customers and strong market share gains in the US and Canada. The company slightly raised its full-year adjusted EPS guidance to $5.34 at the midpoint. During the earnings call, analysts questioned the sustainability of US dental consumables growth and the timing of value creation benefits. CFO Ronald South indicated most operating income improvements from these initiatives would materialise in the second half of the year.

Yahoo Finance
Aug 4th, 2026
Henry Schein raises 2026 guidance after Q2 sales hit $3.5B on dental gains

Henry Schein reported second-quarter sales of $3.5 billion, up 6.7% year-over-year, driven by 4.6% internal local-currency growth and foreign exchange benefits. The healthcare distributor raised its full-year guidance following stronger-than-expected performance. GAAP net income rose to $94 million, or $0.82 per diluted share, from $86 million a year earlier. Non-GAAP earnings reached $1.27 per share, up 15.5% from $1.10 in the prior-year period. Operating margins expanded across all segments. GAAP operating margin increased 27 basis points to 4.94%, whilst non-GAAP operating margin grew 25 basis points to 7.21%. US dental merchandise sales climbed 8.3%, including 6.5% internal growth, with the company reporting market-share gains. Chief Executive Officer Fred Lowery attributed results to operational execution and early benefits from its value-creation programme.

Yahoo Finance
Jun 23rd, 2026
Henry Schein stock gains 9.4% over 52 weeks, trails Nasdaq's 33.3% surge

Henry Schein (HSIC), a $9 billion healthcare distribution company, has underperformed the Nasdaq Composite despite recent gains. The stock is up 5.7% over three months, trailing the Nasdaq's 19.2% rise during the same period. Year-to-date, HSIC has gained 4.1% compared to the Nasdaq's 12.6% advance. The Melville, New York-based company, which supplies dental, medical and laboratory products to over one million customers, reported stronger-than-expected first-quarter results on 5 May. Adjusted earnings per share of $1.32 beat analyst estimates of $1.20, whilst revenue of $3.4 billion exceeded forecasts of $3.3 billion. Despite softer medical segment demand from a milder flu season, strength in Home Solutions and technology offerings offset the impact. The company expects full-year adjusted EPS between $5.23 and $5.37.

Fortune
Jun 19th, 2026
11 Black Fortune 500 CEOs lead companies with over $427B in combined revenues

Eleven Black CEOs currently lead Fortune 500 companies, representing just 2% of America's largest corporations but marking a record high that has doubled since 2021. These companies collectively generated $432 billion in revenue and hold a combined market value of $405 billion. The roster includes Marvin Ellison of Lowe's, the first Black CEO to lead two different Fortune 500 companies, and Thasunda Brown Duckett of TIAA, one of only two Black women currently serving as Fortune 500 chief executives. Other leaders include Peter Akwaboah (Fannie Mae), Christopher Womack (Southern Company), and Calvin Butler (Exelon). Despite comprising 14% of the overall US workforce, Black employees represent only 7% of managers and 4-5% at senior levels, according to McKinsey research. Throughout Fortune 500 history, only 28 Black CEOs have led these companies.

Yahoo Finance
May 15th, 2026
Henry Schein beats Q1 estimates with $3.37B revenue as dental market share gains offset light flu season

Henry Schein reported first-quarter revenue of $3.37 billion, beating analyst estimates of $3.34 billion, with adjusted earnings per share of $1.32 surpassing expectations of $1.22. The healthcare distributor's performance was driven by strong gains in US dental and global technology segments. CEO Frederick Lowery attributed growth to market share gains and stable dental procedure volumes, supported by merchandise price increases and investments from dental service organisations. The medical business faced headwinds from a lighter flu season affecting point-of-care diagnostics. Analysts questioned gross margin sustainability amid rising oil prices and earnings growth prospects without restructuring. Management highlighted dynamic pricing and proprietary brand growth as margin protection strategies. The company reiterated full-year adjusted EPS guidance of $5.30 at the midpoint, with market capitalisation reaching $7.86 billion.